These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 32398949)

  • 1. Diagnostic, progressive and prognostic performance of m
    Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
    Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
    [No Abstract]   [Full Text] [Related]  

  • 2. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis.
    Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X
    Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of pathology-specific regulators of m
    Li N; Zhan X
    EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering N
    Zhu J; Wang M; Hu D
    Biomed Res Int; 2020; 2020():2514230. PubMed ID: 32258108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
    Zhang D; Zhang D; Wang C; Yang X; Zhang R; Li Q; Xiong Y
    Eur J Cancer Prev; 2022 Jul; 31(4):354-362. PubMed ID: 34519693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Hou J; Shan H; Zhang Y; Fan Y; Wu B
    Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma.
    Li F; Wang H; Huang H; Zhang L; Wang D; Wan Y
    Front Genet; 2020; 11():994. PubMed ID: 33193582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
    Wang S; Zou X; Chen Y; Cho WC; Zhou X
    Front Genet; 2020; 11():580036. PubMed ID: 33584787
    [No Abstract]   [Full Text] [Related]  

  • 10. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
    Liu T; Li C; Jin L; Li C; Wang L
    Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
    Wu C; Rao X; Lin W
    Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
    Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
    Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NME6 as a potential biomarker and therapeutic target involved in immune infiltration for lung adenocarcinoma.
    Luo L; Li Y; Zhang L; Yang L
    Technol Health Care; 2024; 32(4):2277-2291. PubMed ID: 38517815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cancer Genome Atlas (TCGA) based m
    Liu J; Sun G; Pan S; Qin M; Ouyang R; Li Z; Huang J
    Bioengineered; 2020 Dec; 11(1):759-768. PubMed ID: 32631107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
    Xu D; Shao J; Song H; Wang J
    Biomed Res Int; 2020; 2020():9502560. PubMed ID: 32596399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Zhuang J; Lin C; Ye J
    J Cell Physiol; 2020 Sep; 235(9):6300-6306. PubMed ID: 32043594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a m
    Chen J; Yu K; Zhong G; Shen W
    Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.